NCT06853587View on ClinicalTrials.gov

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression

NARecruitingINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Anxiety and Depression
Interventions
OTHER

Pharmacogenetic-guided dosing

SSRI dosing based on Clinical Pharmacogenetics Implementation Consortium's SSRI dosing guidelines.

OTHER

Current prescribing guidelines/recommendations

SSRI dosing based on current prescribing guidelines/recommendations

Trial Locations (1)

T2N 4N1

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER